| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |